Navigation Links
Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month
Date:10/19/2007

Neurologic and Orthopedic Institute of Chicago Offer Complimentary Brain

Scans, Oct 26 & 27, as Part of Clinical Study.

CHICAGO, Oct. 19 /PRNewswire/ --

What: Women diagnosed with HER-2 positive Stage III or Stage IV

breast cancer are eligible to receive an MRI of the brain

at no charge as part of a clinical trial. HER2 is a breast

cancer that tests positive for a protein called human

epidermal growth factor receptor-2 (HER2), which promotes

the growth of cancer cells. Studies have shown that in as

many as 30 percent of breast cancer patients have a

metastasis in the brain. As part of the screening

protocol, participants will undergo a MRI of the brain. The

cost of the MRI is covered by the clinical trial.

Who: Patients who qualify must have an initial primary diagnosis

of high risk and/or HER-2 positive breast cancer. They

must be at least 18 years and should not participate if

they are pregnant.

When: Friday, October 26th, 1 p.m. to 9 p.m.

Saturday, October 27th, 8 a.m. to 5 p.m.

Where: Neurologic and Orthopedic Institute of Chicago

4501 N. Winchester, Chicago

Cost: The brain MRI is free of charge to the patient.

Background: The Chicago Institute of Neurosurgery and Neuroresearch

(CINN) Medical Group will use information from the

screening to determine the potentialbenefit(s) of screening

for brain metastases in patients with advanced breast

cancer.

Study Selection & Enrollment Criteria

Women must be within three to twenty-four months of first

metastases of Stage IV diagnosis or within 12 to 24 months

of initial diagnosis of HER-2 positive Stage III disease.

They must sign a written consent form approved by the CINN

Institutional Review Board (IRB).

Exclusion criteria

Patients with a prior diagnosis of brain metastases or who

are unable to be safely exposed to MRIs. Most common

exclusions include, but are not limited to, pacemakers,

implanted defibrillators, neurostimulators, aneurysm clips,

cochlear devices, or any other institution

contraindications. Women who are pregnant.

CONTACT: Sandi Davis of Chicago Institute of Neurosurgery and Neuroresearch, 773-250-0425, http://www.cinn.org

Media Contact: Lisa Stafford, P.S. Communications, 630-986-8749, Cell: 630-212-1226, Email: lisa@pscommunicationsinc.com


'/>"/>
SOURCE Chicago Institute of Neurosurgery and Neuroresearch
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
4. “Brain fingerprinting”- The new lie detectr
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Two doctors suspended for wrong brain surgery
7. The brain loves a surprise
8. Virus Combats Brain Tumour
9. Increase in sugar...decrease in brain function!!!
10. Alcohol shrinks brain
11. Roller coaster takes brain for a big ride!!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Rancho Palos Verdes, CA (PRWEB) , ... February ... ... well-being, and emotional flow is Dr. Carol Francis' goals for each ... Federation Retreat Conference, Dr. Carol Francis will demonstrate five different brainwave tools which ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth ... most widely used electronic patient signatures solution in healthcare . , Since ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... clinical operations executives and focusing on all facets of clinical trial planning and ... management , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth ...
(Date:2/17/2017)... Atlanta, GA (PRWEB) , ... February 17, 2017 , ... ... ways to reduce readmissions. Driven in large part by the Hospital Readmission Reduction Program ... has been a key focus area for hospitals across the nation. While many providers ...
(Date:2/17/2017)... ... 17, 2017 , ... Dillon Ruxton Insurance, a Florida-based agency ... in the greater Fort Lauderdale metropolitan region, is embarking on a cooperative food ... years, LifeNet 4 Families has provided a broad range of food provision services ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 16, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of innovative therapies ... that Vincent J. Angotti has been ... the company,s board of directors, effective Monday, March ... of experience leading executive and commercial teams at ...
(Date:2/16/2017)... , Feb. 16, 2017  Prescription pain medications ... department visit are necessary for long-term opioid use to ... Feb. 16 th edition of The New ... "Emergency physicians see more patients in acute pain than ... Parker , MD, FACEP, president of the American College ...
(Date:2/16/2017)... , Feb 16, 2017 Research and ... Cancer Diagnostics Market Analysis & Trends - Function, Application, Cancer Type, ... ... Generation Cancer Diagnostics Market is poised to grow at a CAGR ... million by 2025. Some of the prominent ...
Breaking Medicine Technology: